Journal article
Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism
Abstract
Background: Although early evidence concluded a lack of clinical benefit of convalescent plasma therapy (CPT) in COVID-19 management, recent trials have demonstrated the therapeutic potential of CPT in ambulatory care. CPT may also potentiate thromboembolic events, given the presence of coagulation factors and the prothrombotic state of COVID-19.
Objectives: The present study aimed to assess and compare the clinical efficacy and the risk of …
Authors
Li PY; Yu P; Li A; Khalid F; Laureano ML; Crowther MA
Journal
Research and Practice in Thrombosis and Haemostasis, Vol. 7, No. 2,
Publisher
Elsevier
Publication Date
February 2023
DOI
10.1016/j.rpth.2023.100068
ISSN
2475-0379